Christopher Homsy

Christopher F. Homsy

Associate

Christopher F. Homsy

Associate

  • Overview

    Biography

    Christopher Homsy advises companies and investors on mergers & acquisitions, private equity, and venture capital transactions. His practice focuses on counseling companies across various industry sectors (e.g., technology, software, manufacturing, consumer products) on corporate governance and business transactions, including equity financings for strategic investments, restructurings, corporate partnerships, and other exit transactions. Chris is a member of the Business Transactions Group. 

    Mergers and Acquisitions

    Chris represents buyers and sellers in mergers and acquisitions, joint ventures, divestitures, and other strategic transactions.

    General Corporate Matters

    Chris also represents clients on general corporate matters, including corporate governance, entity formation, debt and equity financings, and commercial contracting needs. 

    Prior to joining Robinson+Cole, Chris was an associate in the Mergers & Acquisitions Tax group of KPMG LLP, where he advised clients on state and local tax implications of M&A transactions, reorganizations, and cross-border transactions. Chris began his legal career as a corporate associate at a Rhode Island-based law firm, where he provided counsel to closely-held businesses and tax-exempt organizations.

  • Experience
    • Experience

      Experience

      • Represented Feutune Light Acquisition Corporation, a newly-organized blank check company, in completing its initial public offering on June 21, 2022. The firm’s Capital Markets + Securities Team advised on the offering, which resulted in aggregate gross proceeds to Feutune of $97.75 million.

    • Honors + Awards

      Honors + Awards

      Presented with the 2024 U.S.A. Deal of the Year award, in the small markets category, as part of the Global M&A Network's 15th Annual Americas and Global Markets M&A Atlas Awards in recognition of the acquisition of Medacist Solutions Group by Bluesight, the Medication Intelligence™ Company.

  • NEWS + PRESS
    • News

      R+C in the News

      • February 28, 2024

        Robinson+Cole Deal Team Recognized During Global M&A Network's 2024 15th Annual Americas and Global Markets M&A Atlas Awards

        • » more info
      • August 28, 2023

        Robinson+Cole Represents Prime Number Acquisition I Corp. in Complex deSPAC Transaction with noco-noco Pte. Ltd.

        • » more info
        • View article
      • July 18, 2023

        Robinson+Cole Represents Medacist in its Acquisition by Thoma Bravo

        • » more info
        • View article
      • June 21, 2022

        Capital Markets + Securities Team Pleased to Represent Feutune Light Acquisition Corporation in IPO

        • » more info
        • View article
      • November 3, 2021

        Business Transactions Team Represents SmartEquip in Sale to Ritchie Bros.